当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:422.85亿  总市值:517.45亿
流通股本:13.06亿   总股本:15.98亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金6,326,904,9875,788,951,2504,092,787,9133,973,908,715
  交易性金融资产1,508,578,1821,273,440,5952,231,249,9871,921,163,411
  应收票据及应收账款4,841,289,7095,035,731,2384,726,326,2184,795,035,595
        应收账款4,841,289,7095,035,731,2384,726,326,2184,795,035,595
  应收款项融资992,867,1471,177,632,8471,412,947,1281,303,076,443
  预付款项842,440,127442,839,122380,629,051383,493,024
  其他应收款合计109,378,742104,511,168186,484,643126,170,377
  其中:应收利息4,676,2094,918,0244,838,7464,759,468
        应收股利8,523,036--10,362,560
  存货3,463,037,7203,565,576,6663,827,874,3233,800,617,271
  其他流动资产2,420,655,8032,194,981,8511,630,824,4791,632,516,414
  流动资产合计20,505,152,41719,583,664,73718,489,123,74217,935,981,250
非流动资产:
  长期股权投资4,418,640,3274,295,038,9184,283,042,5664,209,814,370
  其他权益工具投资134,002,727133,922,81063,673,18040,737,361
  其他非流动金融资产30,000,00030,000,00030,000,00030,000,000
  固定资产10,768,840,29110,889,385,19211,029,172,12611,175,832,247
  在建工程1,579,764,5081,426,413,9281,244,567,0031,204,383,858
  使用权资产598,374,198612,554,726612,343,307631,602,929
  无形资产1,207,170,0941,231,637,3481,232,886,2631,223,049,288
  开发支出1,000,0001,000,0007,359,2226,363,986
  商誉98,659,99498,659,99498,659,99498,659,994
  长期待摊费用62,931,57168,884,13374,817,86776,695,960
  递延所得税资产419,491,013414,892,701432,937,060423,026,811
  其他非流动资产280,271,288264,447,950227,646,551260,111,428
  非流动资产合计19,599,146,01119,466,837,70019,337,105,13919,380,278,232
  资产总计40,104,298,42839,050,502,43737,826,228,88137,316,259,482
流动负债:
  短期借款2,939,519,3303,178,689,1263,088,477,3212,457,026,511
  交易性金融负债226,400---
  应付票据及应付账款2,281,811,5102,327,079,1762,439,316,5772,574,351,466
  其中:应付票据191,964,685343,910,750416,836,760205,632,679
        应付账款2,089,846,8251,983,168,4262,022,479,8172,368,718,787
  合同负债392,416,825429,078,437485,390,867539,513,536
  应付职工薪酬479,196,711409,922,561307,452,817621,206,452
  应交税费259,754,707223,647,789245,369,531238,590,447
  其他应付款合计1,831,837,1371,699,812,9641,720,160,2041,815,593,817
        应付股利200,438,432--41,900
  一年内到期的非流动负债453,765,562790,452,752790,410,303870,959,558
  其他流动负债1,519,234,56217,155,78515,955,61220,635,981
  流动负债合计10,157,762,7449,075,838,5909,092,533,2329,137,877,768
非流动负债:
  长期借款193,550,000193,550,000196,000,000342,000,000
  租赁负债534,121,311532,043,352525,264,310537,460,558
  预计负债2,824,4302,999,9653,042,783-
  递延收益318,784,455300,423,751299,506,303294,649,250
  递延所得税负债274,387,463280,640,763278,955,550266,089,833
  非流动负债合计1,323,667,6591,309,657,8311,302,768,9461,440,199,641
  负债合计11,481,430,40310,385,496,42110,395,302,17810,578,077,409
所有者权益(或股东权益):
  实收资本(或股本)1,598,053,3721,598,053,3721,598,053,3721,601,497,373
  资本公积8,741,790,8968,712,761,2867,713,358,9507,731,605,139
  减:库存股131,701,776131,701,776131,701,776191,834,339
  其他综合收益74,401,04174,364,528105,184,636112,993,895
  专项储备2,815,4022,873,3002,908,4712,845,465
  盈余公积1,620,121,2581,620,121,2581,620,121,2581,620,121,258
  未分配利润11,802,356,00211,802,754,07312,186,534,16711,602,291,655
  归属于母公司股东权益合计23,707,836,19523,679,226,04123,094,459,07822,479,520,446
  少数股东权益4,915,031,8304,985,779,9754,336,467,6254,258,661,627
  股东权益合计28,622,868,02528,665,006,01627,430,926,70326,738,182,073
  负债和股东权益合计40,104,298,42839,050,502,43737,826,228,88137,316,259,482
公告日期2025-10-312025-08-292025-04-302025-04-24
审计意见(境内)标准无保留意见
TOP↑